Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evolution and Progress of mRNA Vaccines in the Treatment of Melanoma: Future Prospects
Dimitrios Bafaloukos, Ioanna Gazouli, Christos Koutserimpas, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 636-636
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Malignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling
Radomir M. Slominski, Tae‐Kang Kim, Zorica Janjetović, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2262-2262
Open Access | Times Cited: 17
Neoantigen vaccine nanoformulations based on Chemically synthesized minimal mRNA (CmRNA): small molecules, big impact
Saber İmani, Oya Tagit, Chantal Pichon
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Recent advances of nucleic acid-based cancer biomarkers and biosensors
Jingkun Zhao, Kai Xia, Peng He, et al.
Coordination Chemistry Reviews (2023) Vol. 497, pp. 215456-215456
Closed Access | Times Cited: 21
Synergistic Immunoregulation: harnessing CircRNAs and PiRNAs to Amplify PD-1/PD-L1 Inhibition Therapy
Rui Han, Xiwu Rao, Huiling Zhou, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 4803-4834
Open Access | Times Cited: 7
Macromolecular Poly(N‐isopropylacrylamide) (PNIPAM) in Cancer Treatment and Beyond
Siddhi Throat, Sankha Bhattacharya
Advances in Polymer Technology (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 7
Advances in Melanoma: From Genetic Insights to Therapeutic Innovations
Fernando Valdez-Salazar, Luis Alberto Jiménez-Del Río, Jorge Ramón Padilla‐Gutiérrez, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1851-1851
Open Access | Times Cited: 6
Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy
Bevin Neill, Adriana Retamales Romero, Owen S. Fenton
ACS Applied Bio Materials (2023) Vol. 7, Iss. 8, pp. 4894-4913
Open Access | Times Cited: 13
Advances in Cell and Immune Therapies for Melanoma
Tanase Timis, Sanda Buruiana, Delia Dima, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 98-98
Open Access
Temozolomide‐Promoted MGMT Transcription Contributes to Chemoresistance by Activating the ERK Signalling Pathway in Malignant Melanoma
Meiyi Deng, Bingjie Ren, Jian Zhao, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 3
Open Access
Vaccines in Melanoma
Lindsay A. Janes, Tarek Haykal, Christina V. Angeles
Surgical Oncology Clinics of North America (2025)
Closed Access
Bioinformatics analysis reveals novel tumor antigens and immune subtypes of skin cutaneous melanoma contributing to mRNA vaccine development
Ronghua Yang, Jia He, Deni Kang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Lipid Nanoparticles for mRNA Delivery in Cancer Immunotherapy
Yasir Alshehry, Xiang Liu, Wenhua Li, et al.
The AAPS Journal (2025) Vol. 27, Iss. 3
Closed Access
mRNA vaccines: a powerful tool in cancer treatment
Junda Qian
(2024), pp. 14-14
Closed Access | Times Cited: 2
Potential of Personalized Dendritic Cell-Based Immunohybridoma Vaccines to Treat Prostate Cancer
Simon Hawlina, Robert Zorec, Helena H. Chowdhury
Life (2023) Vol. 13, Iss. 7, pp. 1498-1498
Open Access | Times Cited: 6
Organ-on-a-chip models for development of cancer immunotherapies
M. Chernyavska, Mina Masoudnia, Thomas Valerius, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 12, pp. 3971-3983
Open Access | Times Cited: 6
Sensitizing the Efficiency of ICIs by Neoantigen mRNA Vaccines for HCC Treatment
Rui Han, Yuqian Wang, Lingeng Lu
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 59-59
Open Access | Times Cited: 6
BRAFV600E Metastatic Melanoma Journey: A Perspective from a Patient and his Oncologist
Carsten Finke, Peter Mohr
Advances in Therapy (2024) Vol. 41, Iss. 7, pp. 2576-2585
Open Access | Times Cited: 1
Clock-like Mutation Signature May Be Prognostic for Worse Survival Than Signatures of UV Damage in Cutaneous Melanoma
Fabienne Fröhlich, Egle Ramelyte, Patrick Turko, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3818-3818
Open Access | Times Cited: 2
Intranodal Injection of Immune Activator Demonstrates Antitumor Efficacy in an Adjuvant Approach
Romano Josi, Anete Ogrina, Dominik A. Rothen, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 355-355
Open Access
mRNA: a Physiological Multipurpose Tool for Hitherto Hard-to-treat Neurological and Neuro-Ophthalmological Diseases
G. F. Walter
Neuroscience and Neurological Surgery (2024) Vol. 14, Iss. 2, pp. 01-09
Open Access
Decoding trends in mRNA vaccine research: A comprehensive bibliometric study
Chaobin Zhang, Yuhang Wang, Jianding Peng, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
A first-in-human phase I clinical study with MVX-ONCO-1, a personalized active immunotherapy, in patients with advanced solid tumors.
Rémi Vernet, Eugenio Fernández, Denis Migliorini, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 8, pp. 2089-2100
Open Access
A Comprehensive Review on the Intricate Interplay between COVID-19 Immunization and the New Onset of Pemphigus Foliaceus
Beatrice Bălăceanu-Gurău, Adrian Dumitrascu, Călin Giurcăneanu, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 857-857
Open Access
Exploring Mechanisms and Promising Treatments of Malignant Melanoma
I. W. Pan, Sanchita Bhatnagar, Dan Wang
Journal of Student Research (2024) Vol. 13, Iss. 1
Open Access
Aktuelles zu Impfungen und Immunisierungsstrategien in der Dermatologie
Steffen Schrenker, Luise Erpenbeck
Deleted Journal (2024)
Closed Access
Page 1 - Next Page

Scroll to top